Is Celestica Inc (CLS) a risky stock?
As of July 27, 2026, Clavix grades Celestica Inc (CLS) D for risk, a composite score of 47 out of 100 on an A+ to F scale, which puts CLS in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
CLS price, last 3 months
CLS's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind CLS's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how CLS scores on each, as of July 27, 2026.
What's moving CLS's risk right now
Company-specific signals Clavix flags behind CLS's current grade, drawn from recent news and filings as of July 27, 2026.
Entropy Technologies raised its CLS stake by 220.4% to 27,478 shares, and Andra AP fonden opened a new $6.34 million position. An SEC 8-K material event filing was also logged on July 24, 2026.
Analysts are lifting consensus numbers ahead of the Q2 print, betting on continued strength in AI, cloud, and healthcare end markets, which sets a high bar to beat. Temasek also boosted its CLS stake, signaling institutional confidence.
data highlights CLS's enormous historical gain and asks whether the stock still has upside. The piece frames valuation, not business trend, as the main thing investors need to weigh from here.
Recent CLS news
The latest headlines Clavix ingested for Celestica Inc, newest first. These feed the news-sentiment dimension of CLS's grade.
-
Celestica (NYSE:CLS) is set to report Q2 earnings on July 27, with the article highlighting the company's strong AI infrastructure exposure, 52.8% YoY Q1 revenue growth, record operating margins, and raised full-year guidance as reasons to buy ahead of the print.
What a D grade means
On the Clavix A+ to F scale, CLS's composite of 47 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell CLS or any security. Grades are risk indicators, not predictions of return. Data may be delayed.